WHO ICTRP trial
A study for the metabolomic characteristics of Bevacizumab in the treatment of…
ChiCTR-OCC-14004438 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR-OCC-14004438 |
|---|---|
| Public title | A study for the metabolomic characteristics of Bevacizumab in the treatment of lung cancer |
| Scientific title | A study of metabolomic profiling of response to Bevacizumab in the treatment of non-small cell lung cancer |
| Primary sponsor | PLA General Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Observational study |
| Phase | Post-market |
| Countries | China |
| Conditions | non-small cell lung cancer |
| Interventions | chemotherapy:primary prevention;targeted therapy:primary prevention |
| Registration date | Feb 26, 2014 |
| Target size | chemotherapy:75;targeted therapy:75 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: